Karin Jandeleit‐Dahm

14.4k total citations · 2 hit papers
157 papers, 10.8k citations indexed

About

Karin Jandeleit‐Dahm is a scholar working on Immunology, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Karin Jandeleit‐Dahm has authored 157 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Immunology, 48 papers in Clinical Biochemistry and 46 papers in Molecular Biology. Recurrent topics in Karin Jandeleit‐Dahm's work include Advanced Glycation End Products research (48 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (33 papers) and Chronic Kidney Disease and Diabetes (30 papers). Karin Jandeleit‐Dahm is often cited by papers focused on Advanced Glycation End Products research (48 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (33 papers) and Chronic Kidney Disease and Diabetes (30 papers). Karin Jandeleit‐Dahm collaborates with scholars based in Australia, Germany and United Kingdom. Karin Jandeleit‐Dahm's co-authors include Mark E. Cooper, Merlin C. Thomas, Jay C. Jha, Terri J. Allen, Stephen P. Gray, Anna M.D. Watson, Anna C. Calkin, Bryna S.M. Chow, Markus Lassila and Harald Schmidt and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Karin Jandeleit‐Dahm

153 papers receiving 10.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diabetic kidney disease

2015 793 citations Merlin C. Thomas, Karin Jandeleit‐Dahm et al. profile →
Diabetes and Kidney Disease: Role of Oxidative Stress

2016 518 citations Jay C. Jha, Bryna S.M. Chow et al. Antioxidants and Redox Signaling profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karin Jandeleit‐Dahm Australia	57	3.7k	2.4k	2.2k	1.9k	1.9k	157	10.8k
Frank C. Brosius United States	54	4.1k 1.1×	1.5k 0.6×	761 0.3×	2.3k 1.2×	767 0.4×	146	9.6k
Toshio Miyata Japan	75	4.6k 1.2×	2.7k 1.1×	5.8k 2.6×	4.4k 2.4×	2.7k 1.4×	326	18.4k
Michael Brownlee United States	35	4.4k 1.2×	3.3k 1.4×	4.3k 2.0×	772 0.4×	817 0.4×	58	12.8k
Daisuke Koya Japan	75	6.6k 1.8×	4.1k 1.7×	2.4k 1.1×	4.1k 2.2×	1.1k 0.6×	292	18.9k
Hanna E. Abboud United States	57	3.7k 1.0×	914 0.4×	809 0.4×	2.3k 1.2×	1.6k 0.9×	166	9.0k
Hans‐Peter Hammes Germany	44	4.6k 1.2×	1.9k 0.8×	2.4k 1.1×	515 0.3×	706 0.4×	179	11.7k
Fuad N. Ziyadeh United States	66	6.3k 1.7×	2.9k 1.2×	3.0k 1.4×	6.8k 3.6×	887 0.5×	161	15.7k
Masakazu Haneda Japan	67	4.8k 1.3×	5.4k 2.3×	1.4k 0.6×	3.5k 1.9×	697 0.4×	292	16.1k
Takanori Matsui Japan	54	2.3k 0.6×	3.7k 1.6×	4.3k 2.0×	1.0k 0.5×	770 0.4×	252	9.2k
Lin Sun China	50	4.3k 1.2×	869 0.4×	1.3k 0.6×	2.8k 1.5×	862 0.5×	207	9.6k

Countries citing papers authored by Karin Jandeleit‐Dahm

Since Specialization

Citations

This map shows the geographic impact of Karin Jandeleit‐Dahm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Jandeleit‐Dahm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Jandeleit‐Dahm more than expected).

Fields of papers citing papers by Karin Jandeleit‐Dahm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Jandeleit‐Dahm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Jandeleit‐Dahm. The network helps show where Karin Jandeleit‐Dahm may publish in the future.

Co-authorship network of co-authors of Karin Jandeleit‐Dahm

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Jandeleit‐Dahm. A scholar is included among the top collaborators of Karin Jandeleit‐Dahm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Jandeleit‐Dahm. Karin Jandeleit‐Dahm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maxwell, Scott, Jun Okabe, Harikrishnan Kaipananickal, et al.. (2024). Set7 Methyltransferase and Phenotypic Switch in Diabetic Glomerular Endothelial Cells. Journal of the American Society of Nephrology. 35(6). 733–748. 9 indexed citations

Promptmas, Chamras, et al.. (2024). Simultaneous determination of glucose and albumin in human urine using attenuated total reflection Fourier-transform infrared spectroscopy. Analytical Methods. 16(48). 8341–8351.

Jandeleit‐Dahm, Karin, et al.. (2024). Interplay between epigenetic mechanisms and transcription factors in atherosclerosis. Atherosclerosis. 395. 117615–117615. 3 indexed citations

Richardson, Z.J., et al.. (2022). ATR‐FTIR Spectroscopy for Early Detection of Diabetic Kidney Disease. Analysis & Sensing. 3(4). 7 indexed citations

Claessen, Heiner, Maria Narres, Tatjana Kvitkina, et al.. (2021). Renal Replacement Therapy in People With and Without Diabetes in Germany, 2010–2016: An Analysis of More Than 25 Million Inhabitants. Diabetes Care. 44(6). 1291–1299. 9 indexed citations

Burke, Sandra L., Benjamin Barzel, Nina Eikelis, et al.. (2020). Empagliflozin modulates renal sympathetic and heart rate baroreflexes in a rabbit model of diabetes. Diabetologia. 63(7). 1424–1434. 29 indexed citations

Ouerd, Sofiane, Noureddine Idris-Khodja, Nathanne S. Ferreira, et al.. (2020). Endothelium-restricted endothelin-1 overexpression in type 1 diabetes worsens atherosclerosis and immune cell infiltration via NOX1. Cardiovascular Research. 117(4). 1144–1153. 26 indexed citations

Maalmi, Haïfa, Christian Herder, Klaus Straßburger, et al.. (2020). Biomarkers of Inflammation and Glomerular Filtration Rate in Individuals with Recent-Onset Type 1 and Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 105(12). e4370–e4381. 13 indexed citations

Pickering, R. J., Christos Tikellis, Carlos J. Rosado, et al.. (2018). Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis. Journal of Clinical Investigation. 129(1). 406–421. 67 indexed citations

10.

Jha, Jay C., Jun Okabe, Stephen P. Gray, et al.. (2017). NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy. Diabetes. 66(10). 2691–2703. 121 indexed citations

11.

Gray, Stephen P., Jay C. Jha, Kit Kennedy, et al.. (2017). Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease. Diabetologia. 60(5). 927–937. 89 indexed citations

12.

Jha, Jay C., et al.. (2016). Diabetes and Kidney Disease: Role of Oxidative Stress. Antioxidants and Redox Signaling. 25(12). 657–684. 518 indexed citations breakdown →

13.

Thallas‐Bonke, Vicki, Jay C. Jha, Stephen P. Gray, et al.. (2014). Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy. Physiological Reports. 2(11). e12192–e12192. 87 indexed citations

14.

Wilkinson‐Berka, Jennifer L., Devy Deliyanti, Indrajeetsinh Rana, et al.. (2013). NADPH Oxidase, NOX1, Mediates Vascular Injury in Ischemic Retinopathy. Antioxidants and Redox Signaling. 20(17). 2726–2740. 105 indexed citations

15.

Soldatos, Georgia, Karin Jandeleit‐Dahm, H. Thomson, et al.. (2010). Large artery biomechanics and diastolic dysfunctionin patients with Type 2 diabetes. Diabetic Medicine. 28(1). 54–60. 15 indexed citations

16.

Calkin, Anna C., Terri J. Allen, Markus Lassila, et al.. (2007). Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouse. Atherosclerosis. 195(1). 17–22. 23 indexed citations

17.

Dilley, Rodney J., Caroline A. Farrelly, Terri J. Allen, et al.. (2005). Diabetes induces Na/H exchange activity and hypertrophy of rat mesenteric but not basilar arteries. Diabetes Research and Clinical Practice. 70(3). 201–208. 6 indexed citations

18.

Cooper, Mark E., Karin Jandeleit‐Dahm, & Merlin C. Thomas. (2005). Targets to retard the progression of diabetic nephropathy. Kidney International. 68(4). 1439–1445. 27 indexed citations

19.

Jandeleit‐Dahm, Karin, Jonathan R. Rumble, Alison J. Cox, et al.. (2000). SPARC Gene Expression Is Increased in Diabetes-Related Mesenteric Vascular Hypertrophy. Microvascular Research. 59(1). 61–71. 13 indexed citations

20.

Jandeleit‐Dahm, Karin, Louise M. Burrell, Colin I. Johnston, & Karl Koch. (1997). Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive rats. Journal of Hypertension. 15(6). 643–650. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact